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Objectives The UK Human Papillomavirus (HPV) vaccination programme was introduced in 2008
for girls aged 12–13. The vaccine offers protection against HPV types 16 and 18, which together
cause about 70% of cervical cancers. Vaccinated girls will receive future invitations to the NHS
Cervical Screening Programme, to prevent cancers associated with HPV types not included in the
vaccine, and in case of prior infection with HPV 16 or 18. Little is known about parents’ and girls’
understandings of the protection offered by the vaccine, or the need for future screening.
Design Qualitative interviews with twenty-six parents, and nine girls aged 12–13 who were offered
HPV vaccination through a Primary Care Trust (PCT) in the South-east of England, UK.
Setting Thirty-nine schools, and four general practices.
Results Uncertainty about the level of protection offered by the HPV vaccine was evident among
parents, and to a lesser extent among vaccination-aged girls. There was a lack of understanding
among parents and girls that cervical screening would be required irrespective of vaccination
status; some parental decisions to accept the vaccine were made on the misunderstanding that
vaccination provided complete protection against cervical cancer.
Conclusions Sufﬁcient awareness of the issues related to screening is necessary for informed decision-
making about whether or not to accept the HPV vaccine. Clearer information is needed concerning the
incomplete protection offered by the vaccine, and that cervical screening will still be required. Future
invitations for cervical screening should stress the necessity to attend regardless of HPV vaccination
status, to ensure that high levels of prevention of cervical cancer through screening are maintained.
INTRODUCTION
T
he Human Papillomavirus (HPV) vaccination pro-
gramme was introduced in the UK in 2008 for all
girls aged 12–13.
1 A three-year ‘catch-up’ pro-
gramme was also introduced in September 2008, for girls
aged 14–17.
2 The HPV vaccine used in the UK, Cervarixw,
does not offer complete protection against all cervical
cancers, but against the most common high-risk HPV types
16 and 18, which cause approximately 70% of cases of cer-
vical cancer.
1,3 Previous research suggests that parents’
views on vaccinations play a pivotal role in whether or not
their children are vaccinated
4,5, and in the UK parental
consent is required to vaccinate girls aged under sixteen
years. However, parental perspectives on the HPV vacci-
nation, and the rationale on which decisions are made to
accept or decline the vaccine are unclear, as research to
date has largely examined planned rather than actual
behaviour.
6,7
It is important that parents and girls make informed
decisions about accepting the HPV vaccine based on accurate
understandings of the advantages and disadvantages that
vaccination offers, particularly the level of protection it pro-
vides against cervical cancer.
8 Previous studies have reported
low levels of knowledge and understanding of HPV, and the
HPV vaccine, among parents and vaccinated girls
9,10,11, and
have shown that decisions are often made without sufﬁcient
awareness of relevant issues.
12
The NHS Cervical Screening Programme will continue to
play an important role for vaccinated girls by protecting
them against cervical cancers caused by the high-risk HPV
types not included in the vaccine, and to help prevent
This paper is dedicated to the late Joan Austoker, formerly the director of
the Oxford Group, who died in January 2010 during the course of this
study.
†For membership of the HPV Core Messages Writing Group see list at the
end of the paper.
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2,13–15
There is concern, however, that not all parents and girls
who accept the offer of the HPV vaccine will be aware of
these issues, and may assume they are fully protected from
cervical cancer.
8 Such a misconception among vaccinated
girls could lead to a reduction in future participation in cer-
vical screening, and decreased protection against cervical
cancer as a consequence.
The study we report here is one component of a larger
project which aims to develop evidence-based core HPV
messages, relevant to the new testing and vaccination pro-
grammes, through the synthesis of systematic reviews, a
series of qualitative interviews, and public surveys.
16 The
interview series included an exploration of the information
needs of the ﬁrst cohort of vaccination-aged girls and their
parents, in relation to the decision to accept or decline the
HPV vaccine. Uncertainties emerged surrounding the
relationship between the level of protection the HPV
vaccine provides against cervical cancer, and the need for
future cervical screening. These issues were explored
during subsequent interviews, and it is these exploratory
ﬁndings that are reported in this paper.
METHODS
Participants and procedures
Qualitative research aims to achieve detailed levels of under-
standing through in-depth interviews and systematic analy-
sis, and is the method of choice when little is known about
the issues under investigation. We adopted a qualitative
methodology in this study as an individualized and discur-
sive approach is well suited to the exploration of issues
such as participant awareness, information needs and
understandings in relation to acceptance of the HPV
vaccine, and the investigation of individual values and bar-
riers to uptake or decline in the real life setting.
Qualitative data were collected from 37 parents whose
12–13-year-old daughters had been offered the HPV
vaccine, and 44 girls aged 12–13 years who had been
offered the HPV vaccine during the ﬁrst wave of the HPV
programme (September 2008) within one Primary Care
Trust (PCT) in the South-east of England (Table 1).
There were three key recruitment strategies. First, parents
who gave consent for their daughters to be vaccinated were
recruited via postal invitations sent from four general prac-
tices; all were group practices, two rural, one inner-city
and one urban. Second, girls who received the HPV
vaccine were recruited separately via postal invitations
from two state comprehensive schools. Third, girls, and the
parents of the girls who were not vaccinated were identiﬁed
by the school nurse teams within thirty-nine schools
and recruited via postal invitations; included were city and
rural state comprehensive, independent, faith-based, and
mixed and single sex schools. All potential participants
were sent an invitation pack, which contained an introduc-
tory letter, information sheet, consent form, reply slip and
stamped addressed envelope. Parental agreement for their
daughters to participate in a research interview was
required. Parents and girls were offered a gift voucher (£20
and £10 respectively) to thank them for their participation
in the study.
One of the authors (LH) interviewed the parents between
July 2009 and June 2010. The majority of interviews were
conducted in the parents’ home, and with the exception of
two interviews which took place with both parents, were
conducted solely with the mothers. The girls were inter-
viewed by AC between October 2008 and April 2010.
Thirty-eight girls chose to be interviewed in their own
homes, two with their mothers present; and six girls chose
small group discussions at their school.
Semi-structured interview topic guides were used to
explore parents’ and girls’ reasons for accepting or declining
the HPV vaccination. The topic guide provided a ﬂexible set
of content areas (including understandings of the purpose of
the vaccine, the relationship between HPV and cervical
cancer, the decision-making process, reasons for uptake
and non-uptake, information needs, and future vaccination
intentions) to direct the interview process, while allowing
the participants to raise areas of relevance to them.
Cervical screening as an area of uncertainty and relevance
to the decision-making process originated from the
parents, and, as the study progressed, subsequent interviews
explored the understandings of the HPV vaccine in relation
to cervical screening. The interviews lasted thirty minutes
to one hour and were digitally audio-taped, transcribed ver-
batim, and anonymized. Ethical approval was granted by the
Research Ethics Committee for Wales and written informed
consent was obtained from the participants.
Data analysis
The transcripts were reviewed to identify instances when
parents or girls discussed cervical screening. Data was
retrieved from twenty-six parent, and nine girl interviews
(Table 1). From analysis of these data, themes emerged sur-
rounding the level of protection offered by the HPV vaccine,
the need for future cervical screening, and decision-making
in the context of awareness of the need for future screening.
A thematic analysis was combined with constant comparison
of the data.
17,18 The interviews were compared by selecting
text which described similar or opposing experiences, both
between interviews as well as in the context of each inter-
view. A qualitative software package was used to help with
the management of the data.
19 LH and AC regularly dis-
cussed the coding and interpretation of the data to ensure
Table1 Participant characteristics
Characteristics n ¼ 81
Participants who
commented on cervical
screening issues: parents
n ¼ 26; girls n ¼ 9
Ethnicity
White British 81 35
Declined vaccination
Mothers interviewed 20 10
Mother and father
interviewed
22
Girls interviewed 14 7
Accepted vaccination
Mothers interviewed 15 14
Girls interviewed 30 2
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RESULTS
The ﬁndings are presented around the three key themes
which emerged during the analysis of parents’ and girls’
data, where cervical screening was discussed.
1.The level of protectionoffered by theHPVvaccine
The interviews revealed a range of understandings among
parents about the level of protection the HPV vaccine
offers against cervical cancer. At the time of making the
decision as to whether or not their daughters should have
the HPV vaccine, some parents believed the vaccine
offered complete protection against cervical cancer.
‘Well it’s sort of like a vaccine against cervical cancer:
that’s what it seemed to come across as ...in the press
they seemed to try and make you think this is a cure ...if
they had these injections (they) won’t have to worry
about cervical cancer at all. It would be totally almost
unheard of if you, if everybody had the injections.’
(ID:W9 – mother who consented to have her daughter
vaccinated.)
Other parents were at the opposite end of the spectrum,
believing that the HPV vaccine offered only minimal protec-
tion against the disease.
‘At the end of the day it’s only against one form of cervical
cancer isn’t it? It’s only a minor prevention really.’ (ID:07 –
mother who declined to have her daughter vaccinated.)
A number of parents were well informed, and aware of
the limitations of the vaccine in the level of protection it
afforded.
‘I’ve had abnormal cells myself so I am aware of that (how
cervical cancer develops) and I do get screened very regu-
larly, so I was aware that this is an anti-cervical cancer
vaccine, but I was also aware that it doesn’t protect against
all of the viruses.’ (ID:NP02 – mother who declined to
have her daughter vaccinated.)
Overall, the girls interviewed tended to have a greater
understanding of the level of protection offered by the
HPV vaccine, and realized that by completing the course of
HPV vaccinations they would have a high, but not complete
level of protection against developing cervical cancer.
‘All I really know about how it will prevent me from
getting cancer is it will reduce the risk of it by seventy
percent – and that it’s a lot better than having cancer.’
(ID:21 – 12-year-old girl who received the HPV vaccine.)
2.Decision-making based on
future cervical screening
It became clear that some parents had made the decision
about whether their daughter would receive the HPV
vaccine based on misconceptions about the need for cervical
screening in the future. Several parents had believed that the
vaccine would eliminate the need for cervical screening. The
following mother perceived this to be a key beneﬁt of being
vaccinated, and had made her decision accordingly.
‘It sounded very positive! (the HPV vaccine) ...If it meant
that people didn’t have to have smear tests when they were
older that was great! ...I don’t like smear tests!’ (ID:W10 –
mother who consented to have her daughter vaccinated.)
Another mother, who was unaware that the HPV vaccine
offered limited protection, had also made her decision based
on an inaccurate understanding. At the beginning of the dis-
cussion she had described the vaccine as ‘a miracle’, but
when the incomplete protection offered by the HPV
vaccine was described by the interviewer, she was surprised.
‘I wasn’t aware of that. So you still need belt and braces?’
(ID:W3 – mother who consented to have her daughter
vaccinated.)
The issue of whether or not cervical screening would be
needed in the future was not part of the decision-making
process for all parents. Some had greater levels of under-
standing than others, and were aware that cervical screening
would still be necessary, whether or not the course of HPV
vaccinations had been completed. This awareness was
greater among parents who decided against accepting the
vaccine for their daughter, possibly reﬂecting the additional
information sought about HPV and the vaccine by those in
this group. Rather than being information-based, for a
number of mothers this realization came as a logical exten-
sion to knowing the vaccine only offered partial protection.
‘Oh yes, you would still need to go for a smear I’m sure
but I haven’t had any information on that I don’t think.
But because you can ...there’s always the ﬂuke types that
people get illnesses even after they’ve had the jab, and
there were other sorts of cervical cancer that aren’t caused
by HPV is what I’ve understood ...’ (ID:NP01 – mother
who declined to have her daughter vaccinated.)
At the point of making the decision several parents
remained uncertain as to whether vaccinated girls would
need to attend cervical screening or not.
‘In the future they still need cervical screening? I don’t
know if that is clear actually.’ (ID:07 – mother who con-
sented to have her daughter vaccinated.)
The few girls who had been vaccinated and who were
aware of the cervical screening programme, usually
through their mother’s participation, were generally
unclear of their need to attend screening in the future.
The confusion surrounding screening is evident from the fol-
lowing quotation, which describes the belief that cervical
screening will not be compulsory, but available for those
who feel concerned.
‘Even though you’ve had the injection ...if you’re still
worried then they can say in there (the leaﬂet) “don’t
worry, have the injection but if you’re still worried then
you can have scans when you’re older.” I think that would
be quite good to put in there (the leaﬂet).’ (ID:54 –
12-year-old girl who received the HPV vaccine.)
3.Information needs in relation to the
HPVvaccine and future cervical screening
Several parents did not recall having received any infor-
mation about the need for vaccinated girls to attend cervical
screening in the future. The Department of Health infor-
mation leaﬂet, provided to parents and girls with the invita-
tion for HPV vaccination, states that cervical screening will
still be required for vaccinated girls: ‘The vaccine does not
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women still go for routine cervical screening tests when they are
older’.
20,21 The following parent, who consented to have
her daughter vaccinated on the premise that she would
not need to undergo cervical screening, only became
aware of this misunderstanding when she read the
Department of Health ‘Arm against cervical cancer’ leaﬂet
at the time of interview.
‘I think from reading this leaﬂet it sounds like you still do
have that screening ...I did think that actually (that screen-
ing would not be necessary), but I realize it’s more about
actually reducing the instances ... it’s not reducing the
need to screen.’ (ID:W10 – mother who consented to
have her daughter vaccinated.)
Among parents who discussed cervical screening in the
interviews, there was dissatisfaction with the delivery of
the information about the HPV vaccine, and many felt
they needed to conduct their own independent research
on the topic.
‘To my knowledge it’s not advertised in school that they
should get that (screening) done anyway, unless, at some
point later we start getting leaﬂets to be aware of these
things ... I think a lot of the information is purely what
you can ﬁnd out as a family really.’ (ID:07 – mother who
declined to have her daughter vaccinated.)
Overall there was a profound lack of awareness among the
girls interviewed concerning the NHS Cervical Screening
Programme, with few having heard of smear tests, or cervical
screening. During one interview clariﬁcation was sought from
one girl about whether she had received any information
about the need to attend cervical screening in the future.
Interviewer: One of the messages about the vaccination is
that cervical screening is still really important – to pick up
that remaining 30% (of cancers) that you are still at risk of.
But it doesn’t sound as though anybody’s said that to you?
Girl: No. (ID:51 – 12-year-old girl who received the HPV
vaccine.)
Providing accurate and relevant information concerning
the level of protection that the HPV vaccine offers is vital
in ensuring that vaccinated girls realize the importance of
cervical screening in offering protection against all cervical
cancers. The following mother described the vaccine as
offering a false sense of security, and the danger of vacci-
nated girls believing they are no longer at risk of developing
cervical cancer.
‘It gives you a sense of security ...a false sense of security!
I wouldn’t be surprised if in that age group the number of
people going for smears drops off because you think: “Well
I’ve got protection you know!” You think you’re vaccinated
against everything – it’s hard to remember always that it’s
that thirty percent!’ (ID:NP02 – mother who declined to
have her daughter vaccinated.)
DISCUSSION
This exploratory study has revealed inconsistencies among
parents’ and daughters’ understandings of the HPV vaccine
in two key areas: the degree of protection which the HPV
vaccine offers against cervical cancer, and the need to
attend cervical screening in the future irrespective of HPV
vaccination status. The study ﬁndings also illustrated that
the girls tended to have a greater understanding than their
mothers of the level of protection the HPV vaccine offers
against cervical cancer, but were broadly unaware of the
NHS Cervical Screening Programme.
Some parents had accepted the offer of vaccination based
on the belief that their daughters would not need to attend
cervical screening in the future. The need for future attend-
ance is clearly stated in the Department of Health leaﬂets
provided to girls, and the discussion sheets designed for
parents and girls.
20,21 That this key message is not being
clearly communicated highlights the need for ongoing edu-
cational interventions, tailored to vaccinated girls and their
parents, to clarify that they will not be completely protected
from cervical cancer when vaccinated, therefore cervical
screening at a later stage will remain important for the pre-
vention of cervical cancer. Our ﬁnding that girls have little
awareness of the NHS Cervical Screening Programme is
unsurprising, given the age differences of girls involved in
the vaccination programme, and those eligible for cervical
screening. However, raising awareness of the role of screen-
ing in the prevention of cervical cancer among younger girls
could be beneﬁcial, but will certainly need to be reinforced
at the time of invitation to screening, particularly in light
of recent research highlighting the decline in the number
of young women attending for cervical screening.
22
Parents’ lack of awareness as to whether vaccinated girls
would still need to attend for cervical screening suggests
that parents are not always making fully informed decisions
concerning the HPV vaccine. Despite the availability of the
information relating to the continued need to participate in
cervical screening, it is clearly not being conveyed in a con-
sistent way. If parents are to make informed decisions they
require clearer information, perhaps delivered in an alterna-
tive format to leaﬂets. Highlighting the key messages on the
vaccination consent form, clearly and simply, may be one
way to overcome the problem of written information not
always being referred to, or understood.
The ﬁndings of this study are supported by previous
research, which notes the importance of educating
members of the public to negate the danger that HPV vacci-
nation programmes are viewed as a replacement for the
existing NHS Cervical Screening Programme.
13,14 One
study, conducted within the Australian vaccination pro-
gramme, similarly indicated that the understandings of ado-
lescents at the time of vaccination were unlikely to promote
future participation in cervical screening.
9 Together these
ﬁndings clearly establish that future invitations for
screening will need to stress the importance of attendance
regardless of HPV vaccination status to ensure the future
uptake of cervical screening is not adversely affected,
risking a possible increase in the number of cases of cervical
cancer. The ﬁndings of this current study are also
important because they suggest parents’ understandings of
the need for their vaccinated daughters to attend future
screening may play an important role in their decision to
accept or decline the HPV vaccine. This has not been a
factor previously identiﬁed as important to parents in relation
to decision-making about acceptance of the HPV vaccine.
23
One limitation of the study is the relatively small number
of parents and girls among the participants in this study with
whom cervical screening in relation to the HPV vaccine was
discussed. The importance of these (mis)understandings
emerged at a relatively late stage in the interview process,
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However, the insights that have been gained are important.
The understandings that parents and vaccination-aged girls
have of the role of cervical screening in preventing cancers
caused by the HPV types not covered by the vaccine, and
whether these understandings affect decision-making
about acceptance of the vaccine, need further investigation,
particularly if revised information materials are to be widely
accessible, understandable and relevant.
A major strength of this study is that it explored the
understandings and reactions of those making actual
decisions about acceptance of the HPV vaccine, as opposed
to the use of hypothetical scenarios and imagined reactions.
We included in the sample both girls and parents who had,
and had not, accepted the offer of the vaccine. It is now
equally important to explore the uptake rates of cervical
screening when the ﬁrst cohort of girls offered the HPV
vaccine becomes eligible for screening. While it will be
several years before the younger cohort are invited, the
older girls within the ‘catch-up’ programme are eligible
now for screening within parts of the UK. An exploration
of the impact of HPV vaccination on attendance at cervical
screening would help to determine the relevance of these
exploratory ﬁndings to practice.
...............
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